You are viewing: Saudi Arabia Long Read Sequencing Market analysis
Part of: Long Read Sequencing Market (Global)

The Saudi Arabia Long Read Sequencing Market was valued at $6 Million in 2024 and projected to reach to $21 Million by 2029, representing a compound annual growth rate of 28.3%. Saudi Arabia's long read sequencing market is poised for significant growth through 2029, driven by substantial government investments in healthcare modernization and genomic research infrastructure.

Saudi Arabia Long Read Sequencing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Saudi Arabia Long Read Sequencing Market Trends and Insights

  • This 28.3% compound annual growth rate reflects Saudi Arabia's strategic investments in genomic research infrastructure and precision medicine initiatives aligned with Vision 2030.
  • Saudi Arabia is increasingly adopting long read sequencing technologies across academic institutions, research centers, and healthcare facilities to advance diagnostic capabilities and personalized treatment approaches. The growth trajectory in Saudi Arabia is driven by government support for biotechnology development, rising healthcare expenditure, and growing collaboration between Saudi Arabia's research institutions and international genomics leaders.
  • Saudi Arabia's emphasis on building a knowledge-based economy has catalyzed demand for advanced sequencing platforms capable of detecting complex genetic variations.
  • By 2029, Saudi Arabia is expected to establish itself as a regional hub for genomic research, with long read sequencing becoming integral to clinical and research applications across the kingdom..

Key Market Statistics

  • CAGR (2024-2029) 28.3% CAGR
  • Market Size, 2024 ~USD 6 Million
  • Forecast, 2029 ~USD 21 Million
  • Country Saudi Arabia

Saudi Arabia Long Read Sequencing Market Overview

Vision 2030 Alignment :

Saudi Arabia's long read sequencing market growth is directly supported by Vision 2030 initiatives promoting precision medicine and genomic research infrastructure development across the kingdom.

Rapid Market Expansion :

The market is projected to grow from $6.0 million in 2024 to $21.0 million by 2029, representing a robust 28.3% CAGR driven by increased healthcare investments and research capabilities.

Strategic Infrastructure Investment :

Saudi Arabia is establishing advanced genomic research centers and sequencing facilities, positioning itself as a regional hub for precision medicine and personalized healthcare solutions.

Technology Adoption Acceleration :

Healthcare institutions and research organizations in Saudi Arabia are increasingly adopting long read sequencing technologies for improved diagnostic accuracy and genomic research applications.

Saudi Arabia Long Read Sequencing Market Dynamics

  • The kingdom's commitment to Vision 2030 has catalyzed the establishment of advanced sequencing facilities and research centers, attracting both domestic and international genomic research initiatives.
  • Healthcare providers are increasingly recognizing the clinical value of long read sequencing for rare disease diagnosis and personalized treatment planning. The market expansion is further supported by growing collaboration between Saudi research institutions and global genomic leaders, facilitating technology transfer and expertise development.
  • As precision medicine becomes integral to Saudi Arabia's healthcare strategy, demand for long read sequencing capabilities will accelerate across academic medical centers, diagnostic laboratories, and pharmaceutical research organizations throughout the region..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Saudi Arabia's long read sequencing market is valued at $6.0 million in 2024 and is forecast to grow to $21.0 million by 2029, representing a 28.3% CAGR.
    • Saudi Arabia's Vision 2030 initiative and government investments in biotechnology are primary catalysts driving market expansion and technology adoption.
    • Saudi Arabia is positioning itself as a regional genomics hub through institutional partnerships and infrastructure development in precision medicine.
    • Long read sequencing adoption in Saudi Arabia is accelerating across research institutions, diagnostic centers, and clinical applications for complex genetic analysis.

    Long Read Sequencing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment DATA ANALYSIS (Workflow)
    Forecast Period 2024-2029
    Growth Rate CAGR of 32.8% from 2024 to 2029
    Largest Segment RESEARCH USAGE (Usage)
    Market Size Base Year (Billions) ~USD 0.76 (2024)
    Revenue Forecast (Billions) ~USD 3.13 (2029)
    Segments Covered Offering, Technology, Workflow, Application, Usage, End User

    Saudi Arabia Long Read Sequencing Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Offering

    • Consumables
    • Instruments
    • Services

    By Technology

    • Nanopore Sequencing
    • Single-Molecule Real-Time Sequencing
    • Synthetic Long-Read Sequencing

    By Workflow

    • Data Analysis
    • Sample Preparation
    • Sequencing

    By Application

    • Epigenetics
    • Metagenomics
    • Other Applications
    • Targeted Sequencing
    • Whole-Exome Sequencing
    • Whole-Genome Sequencing

    By Usage

    • Clinical Usage
    • Research Usage

    By End User

    • Academic & Research Institute
    • Academic & Research Institutes
    • Hospitals, Clinics & Diagnostic
    • Hospitals, Clinics, And Diagnostic Labs
    • Other End User
    • Other End Users
    • Pharmaceutical & Biotechnologies Companies
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical & Biotechnology Companies Labs

    Target Audience

    • Genomic Sequencing Equipment Manufacturers : Need market-specific demand forecasts and infrastructure investment data to develop targeted sales strategies and product positioning for Saudi Arabia's rapidly expanding genomic research sector.
    • Healthcare Investment Firms : Require validated market sizing and growth projections to evaluate investment opportunities in Saudi Arabia's precision medicine ecosystem and genomic research infrastructure development.
    • Diagnostic Laboratory Operators : Need insights into Saudi Arabia's adoption trends, institutional partnerships, and clinical demand patterns to plan facility expansion and sequencing service offerings in the kingdom.
    • Pharmaceutical & Biotech Companies : Require market intelligence on Saudi Arabia's genomic research capabilities and precision medicine initiatives to identify collaboration opportunities and clinical trial recruitment potential.
    • Healthcare Policy & Research Institutions : Need comprehensive market data to inform strategic planning, funding allocation, and infrastructure development decisions aligned with Saudi Arabia's Vision 2030 healthcare modernization goals.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise market valuation ($6M in 2024) and verified forecast data ($21M by 2029) specific to Saudi Arabia, enabling accurate business planning and investment decisions in this high-growth market.
    • Vision 2030 Strategic Alignment : Understand how Saudi Arabia's national development agenda directly supports long read sequencing adoption, helping stakeholders align product development and market entry strategies with government priorities.
    • Competitive Landscape Intelligence : Gain insights into Saudi Arabia's unique market dynamics, infrastructure investments, and institutional adoption patterns to identify competitive advantages and partnership opportunities in the region.
    • Investment & Expansion Planning : Access detailed market analysis to support investment decisions, facility planning, and resource allocation for companies seeking to establish or expand genomic sequencing operations in Saudi Arabia.
    • Regulatory & Implementation Insights : Understand Saudi Arabia-specific regulatory environment, healthcare system requirements, and institutional procurement patterns essential for successful market entry and product commercialization.

    Frequently asked questions

    What is the current market size of long read sequencing in Saudi Arabia?

    Saudi Arabia's long read sequencing market was valued at $6.0 million in 2024 and is expected to reach $21.0 million by 2029.

    What is the projected growth rate for long read sequencing in Saudi Arabia?

    Saudi Arabia's long read sequencing market is projected to grow at a compound annual growth rate (CAGR) of 28.3% from 2024 to 2029.

    What factors are driving long read sequencing adoption in Saudi Arabia?

    Key drivers in Saudi Arabia include Vision 2030 government initiatives, increased healthcare spending, institutional investments in genomic research, and growing demand for precision medicine applications.

    Which sectors in Saudi Arabia are adopting long read sequencing technology?

    Long read sequencing adoption in Saudi Arabia spans academic research institutions, diagnostic laboratories, clinical healthcare facilities, and government-supported biotechnology centers.

    How does Saudi Arabia's market compare to global long read sequencing trends?

    Saudi Arabia's 28.3% CAGR is competitive with global growth trends, reflecting the kingdom's strategic focus on genomics and precision medicine as part of its economic diversification strategy.

    RESEARCH METHODOLOGY

    This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI),  PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the long-read sequencing market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Long Read Sequencing Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.

    Stakeholders

    • Academic & Research Institutes
    • Software & Bioinformatics Companies
    • Healthcare & Clinical Laboratories
    • Long-Read Sequencing Technology Vendors
    • Contract Research Organizations (CROs)
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Industry Associations and Professional Societies

    Report Objectives

    • To define, describe, and forecast the long-read sequencing market based on offerings, technology, workflow, application, usage, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall long-read sequencing market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global long-read sequencing market and comprehensively analyze their instruments, consumables, and services portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the long-read sequencing market
    • To benchmark players within the long-read sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Asia Pacific Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Latin America Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Middle East Long-Read Sequencing Market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other application and other end users area into subsegments
    • Cross-segment analysis

    Get the Full Long Read Sequencing Market Report

    Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status